@ecraid.bsky.social
The European Clinical Research Alliance for Infectious Diseases is a not-for profit foundation that advances clinical research in infectious diseases.
@thelancetinfdis.bsky.social @jacopogarlasco.bsky.social @horizoneu.bsky.social
20.10.2025 07:24 — 👍 0 🔁 0 💬 0 📌 0
🦠 New tool to track #antibioticresistance: the Emerging Resistance Index (ERI).
💡Using data from 38 surveillance systems across Europe, researchers found rapid resistance emerging to all new Gram-negative antibiotics.
The ERI could help guide surveillance & policy!
👉Read the article bit.ly/4hgk51g
Meet Eveline Verheijen, our new Site Management Organisation (SMO) Manager!
🔬 Eveline leads our vaccination site in Utrecht - one of the top-performing study sites in NL. Her focus on collaboration, quality & efficiency helps accelerate clinical research.
🔎Read the full interview: bit.ly/SMO-Eveline
💡 The Penta Brighter Future Award provides essential recognition and funding to individuals driving change in maternal and child health.
Honour a leader who is advancing equitable health outcomes and combatting infectious disease at the community level.
👉🏼 Submit your nomination: penta-id.org/bfa/
📩 Our latest newsletter is out!
Discover significant developments at Ecraid, including the launch of our new campaign to foster strategic collaborations, #PartnerForImpact!
📫 Stay informed, subscribe now bit.ly/43kBWhJ
#PartnerWithEcraid #ClinicalResearch #InfectiousDiseases #Education #Knowledge
@marcbonten.bsky.social has dedicated his career to advancing #clinicalmicrobiology & combatting #antimicrobialresistance. In his new role as Vice-Dean Education at @umcutrecht.bsky.social
he continues to inspire the next generation of healthcare scientists & researchers: ecraid.eu/articles/edu...
The #ECDC report on C. auris shows gaps in EU surveillance & IPC. Ecraid is built to fill them:
- Warm-base network for faster diagnosis, prevention, & treatment.
- Single-access infrastructure breaks research silos.
We strengthen the defense against future #AMR threats: bit.ly/PartnerForIm...
Which antibiotic works best for treating moderate to severe community-acquired pneumonia (CAP) 🫁 ? A commentary in Clinical Microbiology and Infection emphasises the urgent need for stronger evidence - because patients deserve better 👇🏼
@escmid.bsky.social @cmicomms.bsky.social
On 15-SEP, the annual #PNEUMO EU F2F meeting with Ecraid’s operational team and funder MSD took place.
It was a fruitful meeting held at MSD headquarters in Haarlem, with a very nice tour around their facility.
Thanks to Kelly Johnson & #MSD NL for the hospitality & for continuous collaboration!
@academicsky.org @medsky.social @idsky.bsky.social @infectiousdiseases.bsky.social
15.09.2025 09:41 — 👍 0 🔁 0 💬 0 📌 0📩 In our latest newsletter you can read more about Ecraid’s September highlights including studies updates and other milestones!
👉🏽 Meet us in Amsterdam at the ERS Congress & World Vaccine Congress. Book a meeting with our team: info@ecraid.eu
📫 Stay informed, subscribe now: bit.ly/EcraidNewsSe...
🦠 Can respiratory viruses like SARS-CoV-2 and influenza reactivate dormant cancer cells? Although widely regarded as a scientific breakthrough and despite firm conclusions, some emphasised that cancer survivors should not be alarmed yet. Read the latest blog post by @marcbonten.bsky.social
19.08.2025 08:47 — 👍 3 🔁 1 💬 0 📌 0
Our Education Newsletter is out now! Packed with opportunities and inspiration for early-career researchers and beyond: upcoming postgraduate courses, new scientific papers, a webinar recording you may have missed, & more resources to boost your knowledge 👉 mailchi.mp/ecraid/ecrai...
23.07.2025 12:23 — 👍 1 🔁 1 💬 0 📌 1
Don't miss this chance to attend this course featuring insightful lectures, interactive afternoon workshops and invaluable network opportunities with other researchers and experts from across Europe & beyond
👇
www.escmid.org/event-detail...
@escmid.bsky.social @umcutrecht.bsky.social
We are looking for a visionary Chief Executive Officer to lead Ecraid into its new chapter. If you are a purpose-driven and people-centred leader with bold ideas, an entrepreneurial spirit and a pan-European mindset, we’re looking for you!
More info 👉 www.ecraid.eu/careers
@idsky.bsky.social @academicsky.org @medsky.social
08.07.2025 12:55 — 👍 0 🔁 0 💬 0 📌 0📩In our latest newsletter you can read more about our upcoming educational opportunities and get the latest updates on publications and study milestones.
👉🏽We're hiring a Chief Executive Officer! Are you interested? Read more in our newsletter.
📫Stay informed, subscribe now: bit.ly/07NewsEcraid
What are ethical, administrative, regulatory and logistical hurdles for delivery of RCTs & can these be qualified? Hot off the presses, this article in @jamanetworkopen.com by Dr.@denisevanhout.bsky.social, the REMAP-CAP investigators & the Ecraid operational team: jamanetwork.com/journals/jam...
07.07.2025 09:33 — 👍 1 🔁 1 💬 0 📌 0
Very pleased to announce a new speaker at our 'Better Methods' course in Athens: Prof. Sotirios Tsiodras! The programme will be updated shortly to reflect his topic.
Registration remains open for this unique learning experience for early-career investigators: www.escmid.org/event-detail...
💡New publication!
Researchers from #ECRAIDBase and ADVANCE-ID (NUS) have co-authored an article analysing the Personalised Randomised Controlled Trial (#PRACTicalTrial) design.
📖 bit.ly/45GgWUT
#ResearchCollaboration #HORIZON2020
@advance-id.bsky.social @horizoneu.bsky.social @hug-ge.bsky.social
@escmid.bsky.social @gardp.bsky.social @jesusrbano.bsky.social @mariskaleeflang.bsky.social
18.06.2025 07:42 — 👍 1 🔁 0 💬 0 📌 0
#DKY that in our post-grad course you can choose between two tracks, join parallel workshops, discuss real-world cases, & network with your peers? 💡
👀Check out the programme, apply for an attendance grant, or register directly to secure your place!
➡️ bit.ly/44a1tdn
#IDSky #ResearchSky #Education
Proud of our partners at University of Geneva for having published an ECRAID-Base article investigating additional analysis methods for the novel Personalised Randomised Controlled Trial (PRACTical) design in @springernature.com:
👉 www.ecraid.eu/projects/ecr...
REMAP-CAP has published a paper in @springernature.com's Intensive Care Medicine Journal investigating whether hydrocortisone improves mortality in severe community-acquired pneumonia 👉 link.springer.com/article/10.1...
#Pneumonia #ClinicalTrials #REMAPCAP
@academicsky.org @idsky.bsky.social @infectiousdz.bsky.social #ClinicalResearch #InfectiousDiseases #NewCollaborations #Education #KnowledgeSharing
10.06.2025 13:50 — 👍 0 🔁 0 💬 0 📌 0📩Check our latest newsletter for: highlights from our recent meeting with key primary care representatives, new collaborations (VAC4EU) and upcoming educational opportunities.
👉🏽Registration is open for the Postgraduate course in Athens!
📫Stay informed, subscribe now: bit.ly/EcraidJune25
@academicsky.org @infectiousdiseases.bsky.social @idsky3.bsky.social #ClinicalResearch #InfectiousDiseases #NewCollaborations #Education #KnowledgeSharing
10.06.2025 13:44 — 👍 0 🔁 0 💬 0 📌 0#warmbasenetwork #hospitalnetwork #clinicalresearch
30.05.2025 10:42 — 👍 0 🔁 0 💬 0 📌 0
Diagnosing & treating infections in #ICUs is complex due to the need for rapid intervention and growing antibiotic resistance. Our head of CLIN-Net Miranda Hopman is at the Intensive Medicine Congress in Lisbon to discuss future collabos & share expertise on building a 'warm-base' research network.
30.05.2025 10:41 — 👍 1 🔁 0 💬 2 📌 0
Join this webinar organised by Ecraid & the European Respiratory Society, tackling adaptive clinical trials designs in the setting of a respiratory infection.
Info & registration 👉 ecraid.eu/news/webinar...
This webinar concludes the Ecraid Training Modules on Adaptive Clinical Trial Designs.
